A new report from the Institute of Medicine (IOM) identifies 12 social and behavioral measures that should be considered for stage three Meaningful Use requirements.
The IOM’s recommendation to the Centers for Medicare & Medicaid Services and to the Office of the National Coordinator for Health Information Technology centers on the idea that capturing this type of psychosocial information for clinical practice could result in better patient care:
“…if standardized social and behavioral data can be incorporated … those data can provide crucial information about factors that influ- ence health and the effectiveness of treatment. Such information is useful for diagnosis, treatment choices, policy, health care system design, and innovations to improve health outcomes and reduce health care costs.”
Read the full report here.